semaglutide molecular structure PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: The unsung heroes of GLP-1

Who should choose tirzepatide

Women who are pregnant or breastfeeding should avoid semaglutide, as its safety in these populations hasnt been established

Choosing the wrong GLP-1 can lead to big problems like slower fat loss, annoying plateaus, ongoing nausea, and a higher chance of giving up early

This difference is due to a single amino acid at the 2nd position in the N-terminal, where GLP-1 has an alanine (Ala8) while exendin-4 has a glycine (Gly2)

Ruiz-PozoVATamayo-TrujilloRCadena-UllauriSFrias-ToralEGuevara-RamrezPPaz-CruzEet al

Wegovy HD may be suitable for: Adults living with obesity Patients requiring additional weight loss support Individuals who have successfully tolerated lower doses of semaglutide Patients working towards significant long-term weight reduction goals Treatment decisions should always be made in consultation with a qualified prescriber